CAMBRIDGE, United Kingdom and MONTREAL, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies, ...

Infosys is collaborating with the University of Cambridge to establish a new Al Lab in London. This lab aims to harness the ...

SCI Semiconductor are very pleased to announce the global-first CHERI-enabled family of devices, based on the RISC-V RV32E ...

A single treatment with a CRISPR-Cas9 based gene editing therapy is enough to replace the daily medication of patients with ...

Virax Biolabs enters distribution agreement with Europa Biosite to commercialize ImmuneSelect in UK & Ireland: London Thursday, October 24, 2024, 12:00 Hrs [IST] Virax Biolabs Gro ...

A single treatment with, a CRISPR-Cas9 based gene editing therapy, is enough to replace the daily medication of patients with hereditary angioedema (HAE), a condition characterized by severe, painful ...

A single treatment with, a CRISPR-Cas9 based gene editing therapy, is enough to replace the daily medication of patients with ...

Researchers expand on their phase one study demonstrating a single treatment with a CRISPR-Cas9-based gene editing therapy, ...

Solve the ritualistic riddle to access the Puppet Camo Suit Thursday, 24 October 2024, Cambridge, UK. Drop onto a terrifying island of scares, shocks and thrills with SCUM’s horrifying Halloween event ...

Murphy will lead a New Jersey delegation to the UK next month, the governor’s office announced Wednesday. The trip to London and Cambridge is organized by Choose New Jersey and will “focus on ...

Arm Holdings Plc is cancelling a licence that allowed longtime partner Qualcomm Inc to use Arm intellectual property to ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.